1-5 of 5
Suresh Veeramani, DVM, PhD
Close
Sort by
Journal Articles

Novel IL-2Ralpha (CD25)-Binding RNA Aptamer to Target T Regulatory Cells

Suresh Veeramani, DVM, PhD, Sue E Blackwell, MS, William H Thiel, PhD, Paloma H Giangrande, PhD, George J Weiner, MD
Journal: Blood
Blood (2016) 128 (22): 3697.
https://doi.org/10.1182/blood.V128.22.3697.3697
Published: 2016
Journal Articles

Intratumoral Inhibition of C5a Using Anti-C5a Monoclonal Antibody Inhibits Lymphoma Progression

Suresh Veeramani, DVM, PhD, George J. Weiner, MD
Journal: Blood
Blood (2014) 124 (21): 4506.
https://doi.org/10.1182/blood.V124.21.4506.4506
Published: 2014
Journal Articles

C5a Complement Depletion Suppresses In Vivo B Lymphoma Progression and Enhances Development Of Cellular Anti-Tumor Immune Response

Suresh Veeramani, DVM, PhD, George J. Weiner, MD
Journal: Blood
Blood (2013) 122 (21): 1837.
https://doi.org/10.1182/blood.V122.21.1837.1837
Published: 2013
Journal Articles

C5a Depletion As a Novel Strategy to Inhibit T Regulatory Cells and Enhance Antigen-Specific Immune Responses

Suresh Veeramani, DVM, PhD, George J. Weiner, MD
Journal: Blood
Blood (2012) 120 (21): 3285.
https://doi.org/10.1182/blood.V120.21.3285.3285
Published: 2012
Journal Articles

Complement Enhances Foxp3+ T Regulatory Cell Induction by B Cell Lymphoma

Suresh Veeramani, DVM, PhD, Chris Dahle, MS, George Weiner, MD
Journal: Blood
Blood (2010) 116 (21): 5176.
https://doi.org/10.1182/blood.V116.21.5176.5176
Published: 2010